Seidlerová Jitka, Filipovský Jan, Mayer Otto, Wohlfahrt Peter, Cífková Renata
1] Department of Internal Medicine II, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic [2] Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic.
1] Centre for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital, Charles University in Prague, Prague, Czech Republic [2] Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Hypertens Res. 2014 Jan;37(1):64-8. doi: 10.1038/hr.2013.113. Epub 2013 Sep 19.
Aortic stiffness is strongly related to age and mean arterial pressure (MAP). In the present analysis, we investigated whether antihypertensive treatment modulates the association of the aortic pulse wave velocity (PWV) with age and with MAP in the general population. In the Czech post-MONICA cross-sectional study, we measured the PWV in 735 subjects (mean age 61.2±7.8 years, 54.1% women, 44.3% on antihypertensive medication). We used a linear regression model to assess the effect of treatment on the PWV. The independent covariates in our analysis included sex, age, MAP, heart rate, body mass index, plasma glucose, low-density lipoprotein cholesterol, smoking and observer. The patients receiving treatment were older (64.1±6.7 vs. 58.9±7.8 years), had higher systolic blood pressure (135.9±16.2 vs. 130.1±16.5 mm Hg) and had higher pulse wave velocity (9.1±2.2 vs. 8.2±2.1 m s(-1); P for all <0.0001) than untreated subjects. After adjustment for MAP, the use of treatment modified the association between age and the PWV (regression equations, treated patients 9.68-0.009 × age vs. untreated subjects 6.98+0.020 × age, difference of regression slopes, F=11.2; P=0.0009). In analyses adjusted for age, treatment was associated with a smaller increase of the PWV with MAP (treated patients 9.63-0.006 × MAP vs. untreated subjects 7.18+0.010 × MAP, F=10.70; P=0.0001). These results were driven primarily by subjects whose blood pressure was below 140/90 mm Hg. In the cross-sectional analysis from a random sample of the general population, antihypertensive treatment was associated with a less steep increase in the PWV with age and the mean arterial pressure. Further longitudinal studies are needed to confirm this finding.
主动脉僵硬度与年龄和平均动脉压(MAP)密切相关。在本分析中,我们研究了降压治疗是否会调节一般人群中主动脉脉搏波速度(PWV)与年龄以及与MAP之间的关联。在捷克的莫妮卡(MONICA)横断面研究中,我们测量了735名受试者的PWV(平均年龄61.2±7.8岁,女性占54.1%,44.3%正在接受降压治疗)。我们使用线性回归模型来评估治疗对PWV的影响。我们分析中的独立协变量包括性别、年龄、MAP、心率、体重指数、血浆葡萄糖、低密度脂蛋白胆固醇、吸烟情况和观察者。接受治疗的患者年龄更大(64.1±6.7岁对58.9±7.8岁),收缩压更高(135.9±16.2 mmHg对130.1±16.5 mmHg),脉搏波速度也更高(9.1±2.2 m/s对8.2±2.1 m/s;所有P值均<0.0001),均高于未接受治疗的受试者。在对MAP进行调整后,治疗的使用改变了年龄与PWV之间的关联(回归方程,接受治疗的患者为9.68 - 0.009×年龄,未接受治疗的受试者为6.98 + 0.020×年龄,回归斜率差异,F = 11.2;P = 0.0009)。在对年龄进行调整的分析中,治疗与PWV随MAP的增加幅度较小有关(接受治疗的患者为9.63 - 0.006×MAP,未接受治疗的受试者为7.18 + 0.010×MAP,F = 10.70;P = 0.0001)。这些结果主要由血压低于140/90 mmHg的受试者驱动。在对一般人群随机样本的横断面分析中,降压治疗与PWV随年龄和平均动脉压的增长斜率较小有关。需要进一步的纵向研究来证实这一发现。